Showing results (891-900 of 1,984) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|October 25, 2020
PET imaging of neuroinflammation in neurological disordersWilliam C Kreisl, Min-Jeong Kim, Jennifer M Coughlin, et al.The Lancet. Neurology|January 22, 2019
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialPeter A LeWitt, Robert A Hauser, Rajesh Pahwa, et al.The Lancet. Neurology|January 22, 2019
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersOlga Ciccarelli, Jeffrey A Cohen, Stephen C Reingold, et al.The Lancet. Neurology|November 13, 2020
New therapies for neuromyelitis optica spectrum disorderMichael Levy, Kazuo Fujihara, Jacqueline PalaceThe Lancet. Neurology|November 27, 2020
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trialMark Obermann, Steffen Nägel, Claudia Ose, et al.The Lancet. Neurology|February 18, 2018
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind studyClive Ballard, Carol Banister, Zunera Khan, et al.The Lancet. Neurology|February 18, 2018
Diagnostic challenges in epilepsy: seizure under-reporting and seizure detectionChristian E Elger, Christian HoppeThe Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.The Lancet. Neurology|September 19, 2020
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenuesRalph H B Benedict, Maria Pia Amato, John DeLuca, et al.Pageof 199